# Ethos Technologies Inc. (LIFE) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $39.85, market value $3.8 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Ethos Technologies Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.35**. A PEG of 0.35 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 6.7×**. Each dollar of revenue is priced at 6.7×.
- **Free-cash-flow yield: 2.3%**. Free cash flow equals 2.3% of the market value.

## Profitability
- **Operating margin: -20.1%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: 18.4%**. 18.4% of each dollar of sales reaches the bottom line.
- **Return on equity: -295.0%**. Return on equity is negative because earnings are negative.
- **Return on assets: -22.5%**. Each dollar of assets produces -22.5% of profit.

## Growth
- **Revenue growth (1 yr): 52.0%**. Revenue grew 52.0% over the last year.
- **EPS growth (1 yr): 43.5%**. Earnings per share rose 43.5%, slower than revenue, so margins compressed.

## Financial health
- **Current ratio: 2.17** (quick 2.17). Current assets cover the next year's liabilities 2.17 times.
- **Altman Z-score: 18.38**. A Z-score of 18.38 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Ethos Technologies Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (8 analysts). 8 analysts cover Ethos Technologies Inc.; the consensus is strong_buy, with an average price target of $34.88 (-12% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **From 52-week high: -2.7%** (321.7% above the low). Trading within 5% of its 52-week high.
- **RSI (14-day): 71**. An RSI of 71 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 1.89** (volatility 96%). Beta of 1.89 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=LIFE · Page: https://foliofundamentals.com/stocks/life

Not investment advice.